Genetic Technologies Limited advised that Mr. Tony Di Pietro has provided his notice of resignation as Chief Financial Officer (CFO) of the Company. The Company has commenced a search for a new CFO with requisite dual ASX and Nasdaq listed company expertise. Mr. Di Pietro will remain in the role of CFO until a replacement commences with GTG or the end of March 2024, whichever date is the earliest.